The HOPE-3 trial (Heart Outcomes Prevention Evaluationβ3) found that antihypertensive therapy combined with a statin reduced first stroke among people at intermediate cardiovascular risk. We report secondary analyses of stroke outcomes by stroke subtype, predictors, treatment effects in key subgroups. Methods:Using a 2-by-2 factorial design, 12 705 participants from 21 countries with vascular risk factors …
Continue reading #Antihypertensives and #Statin Therapy for Primary #Stroke Prevention